Debbie Labrie is a seasoned professional with over 20 years of experience in hematology within the biotech and pharmaceutical sectors, primarily in the Boston area. Currently serving as a Key Account Manager at Geron Corporation since April 2024, Labrie previously held the position of Strategic Account Manager at Fennec Pharmaceuticals Inc. from October 2023 to April 2024. From September 2021 to October 2023, Labrie was a Key Account Manager at CTI BioPharma, where responsibilities included launching Vonjo (Pacritinib) for Myelofibrosis in Massachusetts and enhancing therapy adoption. Prior roles include Key Account Manager and Oncology Specialist at Adaptive Biotechnologies Corp. and a Senior Oncology Specialist at Takeda Oncology. Labrie holds a Bachelor of Science in Business Administration from Boston University.
This person is not in any teams
This person is not in any offices